Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013744 220014462 null 76.8 Curative (C) null 2015-09-24 AML18 PILOT TRIAL 1 null 220031045 PILOT TRIAL
220013745 220019820 0 69 Curative (C) 2017-09-27 2017-10-04 Alemtuz+Fludara+Melphalan RIC MUD N null 220031047 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013746 220008181 1.8 95.2 Curative (C) 2017-09-19 2017-11-28 AML18 PILOT TRIAL Y N 220031049 PILOT TRIAL
220013747 220008183 1.7 0 Palliative (P) 2014-01-19 2014-12-19 Dasatinib 99 N 220031051 DASATINIB
220013748 220014464 0 80.9 Curative (C) 2015-06-20 2015-08-04 AML18 PILOT TRIAL Y N 220031051 PILOT TRIAL
220013749 220008184 1.55 90.6 Disease modification (D) 2017-07-25 2017-10-24 Rituximab 02 N 220031065 RITUXIMAB
220013750 220008186 1.85 49.9 null 2013-07-17 2013-07-18 Rituximab 2 N 220031072 RITUXIMAB
220013751 220014465 1.75 84.2 Curative (C) 2015-10-21 2015-10-27 Alemtuz+Fludara+Melphalan RIC MUD N N 220031078 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013752 220014465 1.6 80 Curative (C) 2014-05-11 2014-05-11 Rituximab N N 220031078 RITUXIMAB
220013753 220014466 null 84 Curative (C) 2017-08-09 2017-08-13 Alemtuz+Fludara+Melphalan RIC MUD N N 220031093 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013754 220014467 1.79 102 Curative (C) 2016-06-06 2016-06-06 AML 18 TRIAL 01 N 220031094 AML18 TRIAL
220013755 220014468 1.9 90.35 Curative (C) 2017-11-06 2017-11-06 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031097 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013756 220014468 1.74 61.8 Curative (C) 2018-01-26 2018-01-26 AML 18 TRIAL Y N 220031097 AML18 TRIAL
220013759 220017900 0 78 Curative (C) 2017-01-12 2017-02-13 AML18 PILOT TRIAL N null 220031113 PILOT TRIAL
220013760 220021553 null 51.3 Disease modification (D) 2017-07-10 2017-07-12 Dasatinib N N 220031113 DASATINIB
220013761 220008192 0 113.8 Curative (C) 2015-02-01 2015-03-21 AML 18 TRIAL 01 N 220031116 AML18 TRIAL
220013762 220008193 1.61 43.6 Curative (C) 2015-11-07 2015-11-08 Rituximab N null 220031119 RITUXIMAB
220013763 220008194 1.83 61 Curative (C) 2017-07-03 2017-07-03 Alemtuz+Fludara+Melphalan RIC MUD N null 220031122 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013764 220008195 1.62 null Curative (C) 2013-01-23 2013-06-17 AML 18 TRIAL Y N 220031128 AML18 TRIAL
220013765 220008196 0 0 Curative (C) 2017-11-16 2017-11-19 AML 18 TRIAL 01 N 220031130 AML18 TRIAL
220013766 220008197 0 null Disease modification (D) 2017-07-29 2017-08-01 Rituximab (Maintenance) N Y 220031137 RITUXIMAB
220013767 220008198 1.7 95 Disease modification (D) 2016-10-12 2016-10-18 Dasatinib 99 N 220031139 DASATINIB
220013769 220014471 1.69 67 Curative (C) 2017-12-13 2017-12-13 Dasatinib N N 220031142 DASATINIB
220013770 220008200 1.61 71.4 null 2016-08-16 2016-08-21 Rituximab (Maintenance) N null 220031142 RITUXIMAB
220013771 220008200 1.79 88.4 Curative (C) 2017-06-12 2017-06-14 AML 18 TRIAL Y N 220031142 AML18 TRIAL
220013772 220008201 1.68 67.2 Curative (C) 2017-04-16 2017-06-11 AML18 PILOT TRIAL N N 220031173 PILOT TRIAL
220013773 220014473 1.57 44.2 Curative (C) 2013-05-31 2013-06-12 Alemtuz+Fludara+Melphalan RIC MUD N N 220031173 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013774 220008202 null 0 Disease modification (D) 2012-09-02 2013-09-25 Dasatinib N N 220031188 DASATINIB
220013775 220014474 1.6 0 Curative (C) 2016-05-10 2016-05-10 Dasatinib N N 220031195 DASATINIB
220013776 220008203 1.6 0 Disease modification (D) null 2016-06-04 Dasatinib N N 220031195 DASATINIB
220013777 220008203 1.9 82.2 Curative (C) 2016-09-11 2016-09-15 Dasatinib N N 220031195 DASATINIB
220013778 220019825 null null Curative (C) 2018-02-07 2018-02-07 Alemtuz+Fludara+Melphalan RIC MUD N N 220031205 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013779 220008204 1.63 null Disease modification (D) 2015-04-20 2015-04-20 Rituximab 02 N 220031209 RITUXIMAB
220013781 220008208 null null Disease modification (D) 2016-05-29 2016-08-23 Dasatinib N N 220031213 DASATINIB
220013782 220008210 1.88 82.8 Curative (C) 2017-07-14 2017-09-19 AML18 PILOT TRIAL N null 220031213 PILOT TRIAL
220013783 220008211 1.66 63.8 Curative (C) 2015-10-22 2015-10-22 AML18 PILOT TRIAL Y N 220031221 PILOT TRIAL
220013784 220008213 1.68 111.5 Curative (C) 2016-05-02 2016-05-06 Dasatinib 02 N 220031225 DASATINIB
220013785 220014477 1.8 null Curative (C) 2017-06-22 2017-06-22 Dasatinib N N 220031227 DASATINIB
220013786 220008215 1.79 60 Curative (C) 2016-02-26 2016-03-01 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220031228 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013787 220008215 1.72 70.2 Disease modification (D) 2017-09-10 2017-09-11 Rituximab null N 220031228 RITUXIMAB
220013788 220017905 1.75 null Curative (C) 2016-10-11 2017-10-06 Dasatinib N N 220031230 DASATINIB
220013789 220008217 null null Disease modification (D) 2018-03-12 2018-03-29 Rituximab 02 null 220031232 RITUXIMAB
220013790 220008217 1.61 55 Curative (C) 2013-12-21 2013-12-24 Alemtuz+Fludara+Melphalan RIC MUD N N 220031232 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013795 220008220 0 57 Curative (C) 2018-08-06 2018-08-06 Dasatinib 02 N 220031249 DASATINIB
220013796 220014481 null 0 Curative (C) null 2018-02-28 Dasatinib N null 220031249 DASATINIB
220013797 220014482 1.7 16.8 Disease modification (D) 2015-12-28 2015-12-31 Rituximab (Maintenance) N N 220031254 RITUXIMAB
220013798 220014482 null 61.3 Curative (C) 2017-03-02 2017-03-09 Alemtuz+Fludara+Melphalan RIC MUD null N 220031254 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013799 220014483 1.64 70.6 Adjuvant (A) 2014-03-22 2014-03-22 AML18 PILOT TRIAL Y N 220031257 PILOT TRIAL
220013800 220014483 1.77 77.4 Disease modification (D) null 2014-05-08 Rituximab N N 220031257 RITUXIMAB
220013801 220019830 1.67 96.8 Curative (C) 2018-02-27 2018-03-28 Alemtuz+Fludara+Melphalan RIC MUD N N 220031258 ALEMTUZUMAB + FLUDARABINE + MELPHALAN